Genome-wide transcriptome directed pathway analysis of maternal pre-eclampsia susceptibility genes

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Yong, Hannah E J ^a   Melton, Phillip E ^b   Johnson, Matthew P ^c   Freed, Katy A ^c   Kalionis, Bill ^a   Murthi, Padma ^a,d   Brennecke, Shaun P ^a   Keogh, Rosemary J ^a   Moses, Eric K ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^d MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN; AMINOPEPTIDASE; INHIBIN; INTERLEUKIN 6; TRANSCRIPTOME; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN A;

ACVR1 GENE; ACVR1C GENE; ACVR2A GENE; ADULT; APOPTOSIS; ARTICLE; BIOINFORMATICS; COL4A1 GENE; COL4A2 GENE; COMPUTER PROGRAM; CONTROLLED STUDY; DATA ANALYSIS; DISEASE SEVERITY; FEMALE; GENE; GENE IDENTIFICATION; HUMAN; HUMAN TISSUE; INHA GENE; INHBB GENE; MAJOR CLINICAL STUDY; PATHOGENESIS; PLACENTA; PREECLAMPSIA; SIGNAL TRANSDUCTION; SUSCEPTIBILITY GENE; CLINICAL TRIAL; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; METABOLISM; MULTICENTER STUDY; PREGNANCY;

ADULT; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; PRE-ECLAMPSIA; PREGNANCY; SIGNAL TRANSDUCTION; TRANSCRIPTOME;

EID: 84930662260     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0128230     Document Type: Article

References (68)

1. Duley L. The global impact of pre-eclampsia and eclampsia. Seminars in perinatology. 2009; 33 (3):130-7. doi: 10.1053/j.semperi.2009.02.010 PMID: 19464502.
2. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. The Lancet. 2010; 376 (9741):631-44. Epub 2010/07/06. S0140-6736(10)60279-6 [pii] doi: 10.1016/S0140-6736(10)60279-6 PMID: 20598363.
3. Meis PJ, Goldenberg RL, Mercer BM, Iams JD, Moawad AH, Miodovnik M, et al. The preterm prediction study: risk factors for indicated preterm births. Maternal-Fetal Medicine Units Network of the National Institute of Child Health and Human Development. Am J Obstet Gynecol. 1998; 178(3):562-7. Epub 1998/04/16. S0002937898704399 [pii] PMID: 9539527.
4. Saigal S, Doyle LW. An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet. 2008; 371(9608):261-9. Epub 2008/01/22. doi: 10.1016/S0140-6736(08)60136-1 S0140-6736(08)60136-1 [pii] PMID: 18207020.
5. Petrou S, Eddama O, Mangham L. A structured review of the recent literature on the economic consequences of preterm birth. Arch Dis Child Fetal Neonatal Ed. 2011; 96(3):F225-32. Epub 2010/05/22. doi: 10.1136/adc.2009.161117 adc.2009.161117 [pii] PMID: 20488863.
6. Anderson CM. Preeclampsia: exposing future cardiovascular risk in mothers and their children. Journal of Obstetric, Gynecologic, & Neonatal Nursing. 2007; 36(1):3-8. Epub 2007/01/24. JOGN115 [pii] doi: 10.1111/j.1552-6909.2006.00115.x PMID: 17238941.
7. Brown DW, Dueker N, Jamieson DJ, Cole JW, Wozniak MA, Stern BJ, et al. Preeclampsia and the risk of ischemic stroke among young women: results from the Stroke Prevention in Young Women Study. Stroke. 2006; 37(4):1055-9. Epub 2006/02/18. 01.STR.0000206284.96739.ee [pii] doi: 10.1161/01.STR.0000206284.96739.ee PMID: 16484606.
8. Mangos GJ. Cardiovascular disease following pre-eclampsia: understanding the mechanisms. J Hypertens. 2006; 24(4):639-41. Epub 2006/03/15. doi: 10.1097/01.hjh.0000217844.57466.85 00004872-200604000-00007 [pii] PMID: 16531790.
9. Nilsson E, Salonen Ros H, Cnattingius S, Lichtenstein P. The importance of genetic and environmental effects for pre-eclampsia and gestational hypertension: a family study. BJOG. 2004; 111(3):200-6. Epub 2004/02/14PMID: 14961879.
10. Salonen Ros H, Lichtenstein P, Lipworth L, Cnattingius S. Genetic effects on the liability of developing pre-eclampsia and gestational hypertension. Am J Med Genet. 2000; 91(4):256-60. Epub 2000/04/15. doi: 10.1002/(SICI)1096-8628(20000410)91:4〈256::AID-AJMG3〉3.0.CO;2-T [pii] PMID: 10766979.
11. Johnson MP, Fitzpatrick E, Dyer TD, Jowett JB, Brennecke SP, Blangero J, et al. Identification of two novel quantitative trait loci for pre-eclampsia susceptibility on chromosomes 5q and 13q using a variance components-based linkage approach. Molecular human reproduction. 2007; 13(1):61-7. Epub 2006/11/07. doi: 10.1093/molehr/gal095 PMID: 17085769.
12. Moses EK, Fitzpatrick E, Freed KA, Dyer TD, Forrest S, Elliott K, et al. Objective prioritization of positional candidate genes at a quantitative trait locus for pre-eclampsia on 2q22. Molecular human reproduction. 2006; 12(8):505-12. Epub 2006/07/01. doi: 10.1093/molehr/gal056 PMID: 16809377.
13. van Dijk M, Mulders J, Poutsma A, Konst AA, Lachmeijer AM, Dekker GA, et al. Maternal segregation of the Dutch preeclampsia locus at 10q22 with a new member of the winged helix gene family. Nat Genet. 2005; 37(5):514-9. Epub 2005/04/05. ng1541 [pii] doi: 10.1038/ng1541 PMID: 15806103.
14. Chappell S, Morgan L. Searching for genetic clues to the causes of pre-eclampsia. Clin Sci (Lond). 2006; 110(4):443-58. Epub 2006/03/11. CS20050323 [pii] doi: 10.1042/CS20050323 PMID: 16526948.
15. Zhao L, Bracken MB, DeWan AT. Genome-wide association study of pre-eclampsia detects novel maternal single nucleotide polymorphisms and copy-number variants in subsets of the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study cohort. Ann Hum Genet. 2013; 77(4):277-87. Epub 2013/04/05. doi: 10.1111/ahg.12021 PMID: 23551011; PubMed Central PMCID: PMC3740040.
16. Johnson MP, Brennecke SP, East CE, Goring HH, Kent JW Jr, Dyer TD, et al. Genome-wide association scan identifies a risk locus for preeclampsia on 2q14, near the inhibin, beta B gene. PloS one. 2012; 7(3):e33666. Epub 2012/03/21. doi: 10.1371/journal.pone.0033666 PMID: 22432041; PubMed Central PMCID: PMCPMC3303857.
17. Zhao L, Triche EW, Walsh KM, Bracken MB, Saftlas AF, Hoh J, et al. Genome-wide association study identifies a maternal copy-number deletion in PSG11 enriched among preeclampsia patients. BMC Pregnancy Childbirth. 2012; 12:61. Epub 2012/07/04. 1471-2393-12-61 [pii] doi: 10.1186/1471-2393-12-61 PMID: 22748001; PubMed Central PMCID: PMC3476390.
18. Mutze S, Rudnik-Schoneborn S, Zerres K, Rath W. Genes and the preeclampsia syndrome. J Perinat Med. 2008; 36(1):38-58. Epub 2008/01/11. doi: 10.1515/JPM.2008.004 PMID: 18184097.
19. Kleinrouweler CE, van Uitert M, Moerland PD, Ris-Stalpers C, van der Post JA, Afink GB. Differentially expressed genes in the pre-eclamptic placenta: a systematic review and meta-analysis. PloS one. 2013; 8(7):e68991. Epub 2013/07/23. doi: 10.1371/journal.pone.0068991 PONE-D-13-12477 [pii] PMID: 23874842; PubMed Central PMCID: PMC3709893.
20. Louwen F, Muschol-Steinmetz C, Reinhard J, Reitter A, Yuan J. A lesson for cancer research: placental microarray gene analysis in preeclampsia. Oncotarget. 2012; 3(8):759-73. Epub 2012/08/30. doi: 595 [pii] PMID: 22929622; PubMed Central PMCID: PMC3478454.
21. Eide IP, Isaksen CV, Salvesen KÅ, Langaas M, SchØNberg SA, Austgulen R. Decidual expression and maternal serum levels of heme oxygenase 1 are increased in pre-eclampsia. Acta Obstetricia et Gynecologica Scandinavica. 2008; 87(3):272-9. doi: 10.1080/00016340701763015 PMID: 18307065
22. Herse F, Dechend R, Harsem NK, Wallukat G, Janke J, Qadri F, et al. Dysregulation of the Circulating and Tissue-Based Renin-Angiotensin System in Preeclampsia. Hypertension. 2007; 49(3):604-11. doi: 10.1161/01.hyp.0000257797.49289.71 PMID: 17261642
23. Lian IA, Loset M, Mundal SB, Fenstad MH, Johnson MP, Eide IP, et al. Increased endoplasmic reticulum stress in decidual tissue from pregnancies complicated by fetal growth restriction with and without pre-eclampsia. Placenta. 2011; 32(11):823-9. Epub 2011/09/13. doi: 10.1016/j.placenta.2011.08.005 S0143-4004(11)00417-6 [pii] PMID: 21907405; PubMed Central PMCID: PMC3210381.
24. Loset M, Mundal SB, Johnson MP, Fenstad MH, Freed KA, Lian IA, et al. A transcriptional profile of the decidua in preeclampsia. Am J Obstet Gynecol. 2011; 204(1):84 e1-27. Epub 2010/10/12. doi: 10.1016/j.ajog.2010.08.043 S0002-9378(10)01098-7 [pii] PMID: 20934677; PubMed Central PMCID: PMC3011026.
25. Winn VD, Gormley M, Paquet AC, Kjaer-Sorensen K, Kramer A, Rumer KK, et al. Severe preeclampsia-related changes in gene expression at the maternal-fetal interface include sialic acid-binding immunoglobulin-like lectin-6 and pappalysin-2. Endocrinology. 2009; 150(1):452-62. Epub 2008/09/27. doi: 10.1210/en.2008-0990 en.2008-0990 [pii] PMID: 18818296; PubMed Central PMCID: PMC2630905.
26. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005; 102(43):15545-50. Epub 2005/10/04. doi: 0506580102 [pii] doi: 10.1073/pnas.0506580102 PMID: 16199517; PubMed Central PMCID: PMC1239896.
27. Founds SA, Conley YP, Lyons-Weiler JF, Jeyabalan A, Hogge WA, Conrad KP. Altered global gene expression in first trimester placentas of women destined to develop preeclampsia. Placenta. 2009; 30 (1):15-24. Epub 2008/11/26. doi: 10.1016/j.placenta.2008.09.015 S0143-4004(08)00314-7 [pii] PMID: 19027158; PubMed Central PMCID: PMC2667803.
28. Arngrimsson R, Hayward C, Nadaud S, Baldursdottir A, Walker JJ, Liston WA, et al. Evidence for a familial pregnancy-induced hypertension locus in the eNOS-gene region. Am J Hum Genet. 1997; 61(2):354-62. Epub 1997/08/01. doi: S0002-9297(07)64061-0 [pii] doi: 10.1086/514843 PMID: 9311740; PubMed Central PMCID: PMC1715904.
29. Arngrimsson R, Siguroardottir S, Frigge ML, Bjarnadottir RI, Jonsson T, Stefansson H, et al. A genomewide scan reveals a maternal susceptibility locus for pre-eclampsia on chromosome 2p13. Hum Mol Genet. 1999; 8(9):1799-805. Epub 1999/08/11. doi: ddc220 [pii] PMID: 10441346.
30. Guo G, Lade JA, Wilton AN, Moses EK, Grehan M, Fu Y, et al. Genetic susceptibility to pre-eclampsia and chromosome 7q36. Hum Genet. 1999; 105(6):641-7. Epub 2000/01/27PMID: 10647900.
31. Laivuori H, Lahermo P, Ollikainen V, Widen E, Haiva-Mallinen L, Sundstrom H, et al. Susceptibility loci for preeclampsia on chromosomes 2p25 and 9p13 in Finnish families. Am J Hum Genet. 2003; 72 (1):168-77. Epub 2002/12/11. doi: S0002-9297(07)60515-1 [pii] doi: 10.1086/345311 PMID: 12474145; PubMed Central PMCID: PMC378622.
32. Founds SA. Bridging global gene expression candidates in first trimester placentas with susceptibility loci from linkage studies of preeclampsia. J Perinat Med. 2011; 39(4):361-8. Epub 2011/06/23. doi: 10.1515/JPM.2011.045 PMID: 21692683.
33. Jebbink J, Wolters A, Fernando F, Afink G, van der Post J, Ris-Stalpers C. Molecular genetics of preeclampsia and HELLP syndrome - a review. Biochim Biophys Acta. 2012; 1822(12):1960-9. Epub 2012/08/25. doi: 10.1016/j.bbadis.2012.08.004 PMID: 22917566.
34. Yong HE, Murthi P, Borg A, Kalionis B, Moses EK, Brennecke SP, et al. Increased decidual mRNA expression levels of candidate maternal pre-eclampsia susceptibility genes are associated with clinical severity. Placenta. 2014; 35(2):117-24. doi: 10.1016/j.placenta.2013.11.008 PMID: 24331737.
35. Brown MA, Gallery EDM, Gatt SP, Leslie G, Robinson J. Management of Hypertension in Pregnancy - Executive Summary. Med J Australia. 1993; 158(10):700-2PMID: ISI:A1993LB93500013.
36. Brown MA, Hague WM, Higgins J, Lowe S, McCowan L, Oats J, et al. The detection, investigation and management of hypertension in pregnancy: executive summary. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2000; 40(2):133-8. doi: 10.1111/j.1479-828X.2000.tb01136.x PMID: 10925899
37. Du P, Kibbe WA, Lin SM. lumi: a pipeline for processing Illumina microarray. Bioinformatics. 2008; 24 (13):1547-8. Epub 2008/05/10. doi: 10.1093/bioinformatics/btn224 PMID: 18467348.
38. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004; 3:Article3. Epub 2006/05/02. doi: 10.2202/1544-6115.1027 PMID: 16646809.
39. Chang SD, Chao AS, Peng HH, Chang YL, Wang CN, Cheng PJ, et al. Analyses of placental gene expression in pregnancy-related hypertensive disorders. Taiwan J Obstet Gynecol. 2011; 50(3):283-91. Epub 2011/10/28. doi: 10.1016/j.tjog.2011.07.005 S1028-4559(11)00126-4 [pii] PMID: 22030040.
40. Kumar A, Begum N, Prasad S, Agarwal S, Sharma S. IL-10, TNF-alpha & IFN-gamma: potential early biomarkers for preeclampsia. Cell Immunol. 2013; 283(1-2):70-4. Epub 2013/07/25. doi: 10.1016/j.cellimm.2013.06.012 S0008-8749(13)00106-8 [pii] PMID: 23880295.
41. Mori T, Shinohara K, Wakatsuki A, Watanabe K, Fujimaki A. Adipocytokines and endothelial function in preeclamptic women. Hypertens Res. 2010; 33(3):250-4. Epub 2010/01/16. doi: 10.1038/hr.2009.222 hr2009222 [pii] PMID: 20075929.
42. Muttukrishna S, Knight PG, Groome NP, Redman CW, Ledger WL. Activin A and inhibin A as possible endocrine markers for pre-eclampsia. Lancet. 1997; 349(9061):1285-8PMID: 9142063.
43. Ozkan ZS, Simsek M, Ilhan F, Deveci D, Godekmerdan A, Sapmaz E. Plasma IL-17, IL-35, interferon-gamma, SOCS3 and TGF-beta levels in pregnant women with preeclampsia, and their relation with severity of disease. J Matern Fetal Neonatal Med. 2013. Epub 2013/11/02. doi: 10.3109/14767058.2013.861415 PMID: 24175856.
44. Prins JR, Gomez-Lopez N, Robertson SA. Interleukin-6 in pregnancy and gestational disorders. J Reprod Immunol. 2012; 95(1-2):1-14. Epub 2012/07/24. doi: 10.1016/j.jri.2012.05.004 S0165-0378(12)00585-2 [pii] PMID: 22819759.
45. Silver HM, Lambert-Messerlian GM, Star JA, Hogan J, Canick JA. Comparison of maternal serum total activin A and inhibin A in normal, preeclamptic, and nonproteinuric gestationally hypertensive pregnancies. Am J Obstet Gynecol. 1999; 180(5):1131-7. Epub 1999/05/18. doi: S0002937899002689 [pii] PMID: 10329867.
46. Sahay AS, Patil VV, Sundrani DP, Joshi AA, Wagh GN, Gupte SA, et al. A longitudinal study of circulating angiogenic and antiangiogenic factors and AT1-AA levels in preeclampsia. Hypertens Res. 2014. Epub 2014/04/11. doi: 10.1038/hr.2014.71 hr201471 [pii] PMID: 24718301.
47. Myatt L, Clifton RG, Roberts JM, Spong CY, Wapner RJ, Thorp JM Jr, et al. Can changes in angiogenic biomarkers between the first and second trimesters of pregnancy predict development of pre-eclampsia in a low-risk nulliparous patient population? BJOG. 2013; 120(10):1183-91. Epub 2013/01/22. doi: 10.1111/1471-0528.12128 PMID: 23331974.
48. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003; 111(5):649-58. Epub 2003/03/06. doi: 10.1172/JCI17189 PMID: 12618519; PubMed Central PMCID: PMC151901.
49. Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med. 2006; 12(6):642-9. Epub 2006/06/06. doi: nm1429 [pii] doi: 10.1038/nm1429 PMID: 16751767.
50. Lockwood CJ, Oner C, Uz YH, Kayisli UA, Huang SJ, Buchwalder LF, et al. Matrix metalloproteinase 9 (MMP9) expression in preeclamptic decidua and MMP9 induction by tumor necrosis factor alpha and interleukin 1 beta in human first trimester decidual cells. Biol Reprod. 2008; 78(6):1064-72. Epub 2008/02/16. doi: 10.1095/biolreprod.107.063743 biolreprod.107.063743 [pii] PMID: 18276934; PubMed Central PMCID: PMC3045968.
51. Palei AC, Sandrim VC, Amaral LM, Machado JS, Cavalli RC, Duarte G, et al. Association between matrix metalloproteinase (MMP)-2 polymorphisms and MMP-2 levels in hypertensive disorders of pregnancy. Exp Mol Pathol. 2012; 92(2):217-21. Epub 2012/02/14. doi: 10.1016/j.yexmp.2012.01.008 S0014-4800(12)00015-9 [pii] PMID: 22327101.
52. Plaks V, Rinkenberger J, Dai J, Flannery M, Sund M, Kanasaki K, et al. Matrix metalloproteinase-9 deficiency phenocopies features of preeclampsia and intrauterine growth restriction. Proc Natl Acad Sci U S A. 2013; 110(27):11109-14. Epub 2013/06/19. doi: 10.1073/pnas.1309561110 1309561110 [pii] PMID: 23776237; PubMed Central PMCID: PMC3704020.
53. Zhang Z, Zhang L, Jia L, Cui S, Shi Y, Chang A, et al. AP-2alpha suppresses invasion in BeWo cells by repression of matrix metalloproteinase-2 and -9 and up-regulation of E-cadherin. Mol Cell Biochem. 2013; 381(1-2):31-9. Epub 2013/05/11. doi: 10.1007/s11010-013-1685-8 PMID: 23660954.
54. Li W, Mata KM, Mazzuca MQ, Khalil RA. Altered matrix metalloproteinase-2 and -9 expression/activity links placental ischemia and anti-angiogenic sFlt-1 to uteroplacental and vascular remodeling and collagen deposition in hypertensive pregnancy. Biochem Pharmacol. 2014; 89(3):370-85. Epub 2014/04/08. doi: 10.1016/j.bcp.2014.03.017 S0006-2952(14)00204-4 [pii] PMID: 24704473.
55. Munaut C, Lorquet S, Pequeux C, Coulon C, Le Goarant J, Chantraine F, et al. Differential expression of Vegfr-2 and its soluble form in preeclampsia. PloS one. 2012; 7(3):e33475. Epub 2012/03/20. doi: 10.1371/journal.pone.0033475 PONE-D-11-12576 [pii] PMID: 22428059; PubMed Central PMCID: PMC3299790.
56. Aggarwal PK, Chandel N, Jain V, Jha V. The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia. J Hum Hypertens. 2012; 26(4):236-41. Epub 2011/04/01. doi: 10.1038/jhh.2011.29 jhh201129 [pii] PMID: 21451568.
57. Bauer V, Sotnikova R. Nitric oxide - the endothelium-derived relaxing factor and its role in endothelial functions. Gen Physiol Biophys. 2010; 29(4):319-40. Epub 2010/12/16PMID: 21156995.
58. Kalkunte S, Boij R, Norris W, Friedman J, Lai Z, Kurtis J, et al. Sera from preeclampsia patients elicit symptoms of human disease in mice and provide a basis for an in vitro predictive assay. Am J Pathol. 2010; 177(5):2387-98. Epub 2010/10/05. doi: 10.2353/ajpath.2010.100475 S0002-9440(10)60291-X [pii] PMID: 20889559; PubMed Central PMCID: PMC2966797.
59. Lian IA, Langaas M, Moses E, Johansson A. Differential gene expression at the maternal-fetal interface in preeclampsia is influenced by gestational age. PloS one. 2013; 8(7):e69848. Epub 2013/08/13. doi: 10.1371/journal.pone.0069848 PMID: 23936112; PubMed Central PMCID: PMC3729459.
60. Hsu P, Nanan RK. Innate and Adaptive Immune Interactions at the Fetal-Maternal Interface in Healthy Human Pregnancy and Pre-Eclampsia. Front Immunol. 2014; 5:125. Epub 2014/04/16. doi: 10.3389/fimmu.2014.00125 PMID: 24734032; PubMed Central PMCID: PMC3975095.
61. Erlebacher A. Immunology of the maternal-fetal interface. Annu Rev Immunol. 2013; 31:387-411. Epub 2013/01/10. doi: 10.1146/annurev-immunol-032712-100003 PMID: 23298207.
62. Knofler M. Critical growth factors and signalling pathways controlling human trophoblast invasion. Int J Dev Biol. 2010; 54(2-3):269-80. Epub 2009/10/31. doi: 10.1387/ijdb.082769mk 082769mk [pii] PMID: 19876833; PubMed Central PMCID: PMC2974212.
63. Whitley GS, Cartwright JE. Trophoblast-mediated spiral artery remodelling: a role for apoptosis. J Anat. 2009; 215(1):21-6. Epub 2009/02/14. doi: 10.1111/j.1469-7580.2008.01039.x JOA1039 [pii] PMID: 19215319; PubMed Central PMCID: PMC2714635.
64. Sharp AN, Heazell AE, Baczyk D, Dunk CE, Lacey HA, Jones CJ, et al. Preeclampsia is associated with alterations in the p53-pathway in villous trophoblast. PloS one. 2014; 9(1):e87621. Epub 2014/02/06. doi: 10.1371/journal.pone.0087621 PONE-D-13-34686 [pii] PMID: 24498154; PubMed Central PMCID: PMC3907567.
65. Monboisse JC, Oudart JB, Ramont L, Brassart-Pasco S, Maquart FX. Matrikines from basement membrane collagens: a new anti-cancer strategy. Biochim Biophys Acta. 2014; 1840(8):2589-98. Epub 2014/01/11. doi: 10.1016/j.bbagen.2013.12.029 S0304-4165(14)00002-6 [pii] PMID: 24406397.
66. Colorado PC, Torre A, Kamphaus G, Maeshima Y, Hopfer H, Takahashi K, et al. Anti-angiogenic cues from vascular basement membrane collagen. Cancer Res. 2000; 60(9):2520-6. Epub 2000/05/16PMID: 10811134.
67. Kamphaus GD, Colorado PC, Panka DJ, Hopfer H, Ramchandran R, Torre A, et al. Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth. J Biol Chem. 2000; 275(2):1209-15. Epub 2000/01/08PMID: 10625665.
68. Johnson MP, Brennecke SP, East CE, Dyer TD, Roten LT, Proffitt JM, et al. Genetic dissection of the pre-eclampsia susceptibility locus on chromosome 2q22 reveals shared novel risk factors for cardiovascular disease. Molecular human reproduction. 2013; 19(7):423-37. Epub 2013/02/20. doi: 10.1093/molehr/gat011 gat011 [pii] PMID: 23420841; PubMed Central PMCID: PMC3690803.